146 related articles for article (PubMed ID: 15454198)
1. Metastatic intramammary lymph nodes as the primary presenting sign of breast cancer.
Kouskos E; Rovere GQ; Ball S; Koh DM; Freeman A
Breast; 2004 Oct; 13(5):416-20. PubMed ID: 15454198
[TBL] [Abstract][Full Text] [Related]
2. Intramammary lymph nodes and breast cancer: a marker for disease severity, or just another lymph node?
Guth AA; Mercado C; Roses DF; Hiotis K; Skinner K; Diflo T; Cangiarella J
Am J Surg; 2006 Oct; 192(4):502-5. PubMed ID: 16978960
[TBL] [Abstract][Full Text] [Related]
3. Occult breast cancer presenting as axillary metastases.
Yamaguchi H; Ishikawa M; Hatanaka K; Uekusa T; Ishimaru M; Nagawa H
Breast; 2006 Apr; 15(2):259-62. PubMed ID: 15996865
[TBL] [Abstract][Full Text] [Related]
4. Intramammary lymph nodes: patterns of discovery and clinical significance.
Vijan SS; Hamilton S; Chen B; Reynolds C; Boughey JC; Degnim AC
Surgery; 2009 May; 145(5):495-9. PubMed ID: 19375607
[TBL] [Abstract][Full Text] [Related]
5. Axillary gland involvement in breast carcinomas is not always metastatic: a case report.
Babu ED; Tariq N; Aref FA; Vashisht R
Int Surg; 2004; 89(3):150-1. PubMed ID: 15521251
[TBL] [Abstract][Full Text] [Related]
6. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
[TBL] [Abstract][Full Text] [Related]
7. Axillary nodal metastasis of occult breast primary cancer.
Tamiolakis D; Antoniou C
Chirurgia (Bucur); 2008; 103(4):467-71. PubMed ID: 18780622
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis.
Varadarajan R; Edge SB; Yu J; Watroba N; Janarthanan BR
Oncology; 2006; 71(5-6):456-9. PubMed ID: 17690561
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of marginal adipose tissue invasion in ductal carcinoma of the breast.
Yamaguchi J; Ohtani H; Nakamura K; Shimokawa I; Kanematsu T
Am J Clin Pathol; 2008 Sep; 130(3):382-8. PubMed ID: 18701411
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
11. Metastases to the internal mammary lymph nodes as the only spread of ductal breast cancer: case description.
Bebenek M; Jedrzejuk D; Milewicz A
J BUON; 2008; 13(4):585-7. PubMed ID: 19145687
[TBL] [Abstract][Full Text] [Related]
12. [Performance of 18F-FDG PET/CT in the detection of primary breast cancer and staging of the regional lymph nodes].
Zhao TT; Li JG; Li YM
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):206-9. PubMed ID: 17649638
[TBL] [Abstract][Full Text] [Related]
13. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
[TBL] [Abstract][Full Text] [Related]
14. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
[TBL] [Abstract][Full Text] [Related]
15. Preoperative lymphatic mapping does not predict the number of axillary sentinel lymph nodes identified during surgery in breast cancer patients.
Carmon M; Hain D; Shapira J; Golomb E
Breast J; 2006; 12(5):424-7. PubMed ID: 16958959
[TBL] [Abstract][Full Text] [Related]
16. Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis.
Shinozaki M; Hoon DS; Giuliano AE; Hansen NM; Wang HJ; Turner R; Taback B
Clin Cancer Res; 2005 Mar; 11(6):2156-62. PubMed ID: 15788661
[TBL] [Abstract][Full Text] [Related]
17. The presentation of contralateral axillary lymph node metastases from breast carcinoma: a clinical management dilemma.
Huston TL; Pressman PI; Moore A; Vahdat L; Hoda SA; Kato M; Weinstein D; Tousimis E
Breast J; 2007; 13(2):158-64. PubMed ID: 17319857
[TBL] [Abstract][Full Text] [Related]
18. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of activated charcoal-epirubicin suspension for treatment of breast cancer with axillary metastasis].
Wu WJ; Zeng J; Pan CE
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1812-4. PubMed ID: 17259127
[TBL] [Abstract][Full Text] [Related]
20. Clinical importance of preoperative detection of the apical lymph node metastasis in patients with breast carcinoma.
Güven HE; Bulak H; Turanli S; Oral S
Singapore Med J; 2007 Jan; 48(1):31-3. PubMed ID: 17245513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
